Annual report pursuant to Section 13 and 15(d)

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.19.1
NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2018
Antidilutive securities excluded from computation of earnings per share
We did not include the following potentially dilutive securities in the computation of diluted net loss per common share because the securities were anti-dilutive during the periods presented:
 
 
 
For the years ended December 31,
 
 
 
2018
 
 
2017
 
 
2016
 
Warrants
 
 
1,820,686
 
 
 
2,934,685
 
 
 
3,736,617
 
Stock options
 
 
5,841,805
 
 
 
5,429,727
 
 
 
4,771,560
 
Total
 
 
7,662,491
 
 
 
8,364,412
 
 
 
8,508,177
 
Employee Stock Option [Member]  
Stock-based compensation allocation
The following table summarizes stock-based option compensation for 2018, 2017 and 2016, which was allocated as follows:
 
 
 
For the years ended December 31,
 
 
 
2018
 
 
2017
 
 
2016
 
Research and development
 
$
3,913,000
 
 
$
1,668,000
 
 
$
1,219,000
 
General and administrative
 
 
4,265,000
 
 
 
2,976,000
 
 
 
3,610,000
 
Stock-based compensation expense included in operating expense
 
 
8,178,000
 
 
 
4,644,000
 
 
 
4,829,000
 
Total stock-based compensation expense
 
 
8,178,000
 
 
 
4,644,000
 
 
 
4,829,000
 
Tax benefit
 
 
 
 
 
 
 
 
 
Stock-based compensation expense, net of tax
 
$
8,178,000
 
 
$
4,644,000
 
 
$
4,829,000
 
Restricted Stock [Member]  
Stock-based compensation allocation
The following table summarizes restricted stock-based compensation for 2018, 2017 and 2016, which was allocated as follows:
 
 
 
For the years ended December 31,
 
 
 
2018
 
 
2017
 
 
2016
 
Research and development
 
$
 
 
$
 
 
$
200,000
 
General and administrative
 
 
688,000
 
 
 
1,272,000
 
 
 
3,232,000
 
Stock-based compensation expense included in operating expense
 
 
688,000
 
 
 
1,272,000
 
 
 
3,432,000
 
Total stock-based compensation expense
 
 
688,000
 
 
 
1,272,000
 
 
 
3,432,000
 
Tax benefit
 
 
 
 
 
 
 
 
 
Stock-based compensation expense, net of tax
 
$
688,000
 
 
$
1,272,000
 
 
$
3,432,000